BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $197,000 | +15.2% | 58,600 | 0.0% | 0.00% | – |
Q4 2018 | $171,000 | -52.6% | 58,600 | 0.0% | 0.00% | – |
Q3 2018 | $361,000 | -16.4% | 58,600 | 0.0% | 0.00% | – |
Q2 2018 | $432,000 | +48.5% | 58,600 | +32.3% | 0.00% | – |
Q1 2018 | $291,000 | -22.0% | 44,300 | 0.0% | 0.00% | – |
Q4 2017 | $373,000 | -27.1% | 44,300 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $512,000 | -1.0% | 44,300 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $517,000 | -5.5% | 44,300 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $547,000 | +37.1% | 44,300 | +51.2% | 0.00% | 0.0% |
Q4 2016 | $399,000 | -31.6% | 29,300 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $583,000 | +53.4% | 29,300 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $380,000 | +19.1% | 29,300 | -17.0% | 0.00% | 0.0% |
Q1 2016 | $319,000 | -45.6% | 35,300 | +22.1% | 0.00% | 0.0% |
Q4 2015 | $586,000 | +39.5% | 28,900 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $420,000 | +181.9% | 28,900 | +312.9% | 0.00% | – |
Q2 2015 | $149,000 | – | 7,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
ARK Investment Management | 417,433 | $538,000 | 0.01% |
ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |